首页> 外国专利> System, Method and Computer Readable Medium to Estimate the Post-Treatment Blood Cell Sub Type Count in Patients Treated via Radiation Therapy

System, Method and Computer Readable Medium to Estimate the Post-Treatment Blood Cell Sub Type Count in Patients Treated via Radiation Therapy

机译:系统,方法和计算机可读介质来估算通过放射治疗治疗患者治疗后的血细胞亚型计数

摘要

A system, method, and computer readable medium for estimating the patient specific and plan specific radiation dose delivered to any type of circulating blood cell type or sub-type, such as, but not limited to, T lymphocytes, B lymphocytes, natural killer cells, erythrocytes, or neutrophils, and predicting time dependent fractional blood count and cell kill following radiation therapy treatment. Additionally, the system, method, and computer readable medium provide parameters such as a dose dependent lymphocyte kill function and average net release rate of new lymphocytes into circulating blood, which also includes the proliferation of existing cells and natural death of lymphocytes in blood. Determining lymphocyte kill following Stereotactic Body radiation therapy (SBRT) to lung tumors is an example of an application of the system, method, and computer readable medium.
机译:用于估计患者特异性的系统,方法和计算机可读介质,并将递送到任何类型的循环血细胞类型或亚型的特定辐射剂量,例如但不限于T淋巴细胞,B淋巴细胞,天然杀伤细胞 ,红细胞或中性粒细胞,并预测时间依赖性分数血计和细胞在放射治疗后杀死。 另外,系统,方法和计算机可读介质提供了诸如剂量依赖性淋巴细胞杀死功能和新淋巴细胞的平均净释放率为循环血液的参数,其还包括血液中淋巴细胞的产量和天然死亡的增殖。 确定淋巴细胞杀死型立体定位体放射治疗(SBRT)至肺肿瘤是系统,方法和计算机可读介质的应用的一个例子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号